Trellus Health provides a multidisciplinary connected care platform that coordinates clinical and behavioral health to support whole-person care for chronic conditions, initially focused on IBD including Crohn’s disease and ulcerative colitis. The company leverages a patent-pending GRITT-IBDTM resilience assessment and a personalized treatment methodology developed at Mount Sinai to support patient resilience and wellness. Trellus aims to improve outcomes and reduce healthcare costs for patients, employers, and the healthcare system through its connected care approach. The company was co-founded by Marla Dubinsky, MD, and Laurie Keefer, PhD, and is led by CEO Monique Fayad. Financially, Trellus announced a $5M seed funding round to support commercialization and growth efforts. It has entered an exclusive multi-year contract with Mount Sinai Health System to commercialize its GRITT-IBDTM methodology.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2020